Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pacific Northwest Dry Eye Sufferers Gain Access to Breakthrough Treatment at Specialty Eyecare Group
  • USA - English


News provided by

Specialty Eyecare Group

Dec 04, 2013, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. David Kading offers dry eye sufferers access to breakthrough treatment at Specialty Eyecare Group
Dr. David Kading offers dry eye sufferers access to breakthrough treatment at Specialty Eyecare Group

Seattle and Kirkland, WA (PRWEB) December 04, 2013 -- Specialty Eyecare Group today announced the treatment availability of LipiFlow®, a breakthrough treatment for Evaporative Dry Eye Disease from TearScience. Headquartered in Morrisville, NC, TearScience’s innovative technology assesses and treats the root cause of Evaporative Dry Eye Disease and is the result of 30 years of research and collaboration with more than 50 scientist and professionals and millions of dollars of investment.

The timing for bringing LipiFlow to our Pacific Northwest Dry Eye Practice was so that we can help patients enjoy the winter without worrying about all the typical Evaportative Dry Eye discomforts that are so common this time of year.

Post this

Specialty Eyecare Group is a local family friendly eyecare clinic with offices in Kirkland and Seattle, WA that specializes in providing infants to seniors the highest level of eyecare. Specialty Eyecare Group is the first clinic to offer the LipiFlow treatment in Kirkland and Seattle, and has developed a dry eye specialty clinic to address the needs of patients who suffer from this difficult disorder. The clinic aims to enrich people’s lives so that they can succeed to their greatest potential.

“Evaporative dry eye, caused by Meibomian Gland Dysfunction (MGD), really starts to show itself this time of year when people go outside to enjoy the brisk air or turn up their heaters, yet experience a burning and itching sensation in their eyes,” said Dr. David Kading, who specializes in treating front of the eye problems like allergies, red eyes, dry eye syndrome, Keratoconus, corneal degenerations, and other diseases. “TearScience was co-founded by one of the most respected optometrist in the world, Dr. Donald R. Korb, and they offer a significant advancement for treating Evaporative Dry Eye that allows the glands that make the oil part of the tears to resume their natural production of lipids which are needed for a healthy tear film. The timing for bringing LipiFlow to our Pacific Northwest Dry Eye Practice was so that we can help patients enjoy the winter without worrying about all the typical Evaportative Dry Eye discomforts that are so common this time of year.”

For patients who suffer from Evaporative Dry Disease, which can cause eyes to feel dry, irritated, gritty and may even cause blurred vision or sensitivity to sunlight, LipiFlow can be used to treat the root cause by unblocking obstructed Meibomian glands located in the eyelids during an in-office procedure. The goal of unblocking the Meibomian glands is to allow them to resume their natural production of lipids for a healthy tear film. Evaporative Dry Eye differs from Aqueous Deficient Dry Eye, where the body is not able to produce adequate moisture to keep the eyes lubricated and are typically treated with pharmaceuticals like Restasis or with over the counter artificial tears. According to a recent study1, 86 percent of dry eye patients suffer from Evaporative Dry Eye. Left untreated, Evaporative Dry Eye is a chronic, progressive disease that will worsen over time. Patients who undergo a LipiView screening gain unprecedented insight into their disease to make informed decisions about treatment if they are a candidate for LipiFlow. In TearScience’s multi-center, randomized, controlled clinical study, 79 percent of patients reported an improvement in overall dry eye symptoms within four weeks of a single LipiFlow treatment.

TearScience gained FDA clearance in February 2012 for its system that assesses and treats Evaporative Dry Eye, which occurs when Meibomian glands in the eyelids become obstructed and do not secrete the oily lipids needed to keep the water portion of tears from evaporating too quickly. TearScience’s assessment and treatment devices include, the LipiView® Ocular Surface Interferometer and the LipiFlow ® Thermal Pulsation System. LipiView provides detailed digital images of a dry eye patient’s tear film for the physician to assess the lipid layer. LipiView is used in conjunction with a dry eye questionnaire and a Meibomian gland evaluation to determine if a patient suffers from Evaporative Dry Eye. LipiView also helps identify if the patient is a partial blinker, which results in the eye not being properly lubricated during blinks.

“I believe LipiFlow and the resulting cascade of technology innovations taking place at TearScience will safely improve the conditions of many sufferers of dry eye,” said Dr. Donald R. Korb, co-founder of TearScience. “Much like modern dentistry, we will continually pioneer preventative approaches to prevent, even before they begin, the debilitating chronic symptoms doctors, including myself, witness every day in our practice."

Click here to watch TearScience customer testimonials or take the Dry Eye Quiz.
1. Lemp MA, et al. Distribution of aqueous deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012:31(5):472-478

About Specialty Eyecare Group
Specialty Eyecare Group is the best of both worlds: we are a family eyecare clinic that takes care of infants to seniors and our doctors all specialize to provide the highest level of eyecare. Made up of specialists, Specialty Eyecare Group is family friendly, innovative and strives to give patients the best eyecare and eyewear solutions that fit their lifestyle. Dr. David Kading’s practice focuses around front of the eye diseases and complicated contact lens fits. Drs. Kristi Kading and Katherine Shen’s practices emphasize pediatrics and visual problems related to head injuries, and eye turns and visually related learning problems.

Claudine Murcia, Specialty Eyecare Group, http://www.specialtyeye.com/index.php, +1 425-821-8900, [email protected]

Modal title

The TearScience Experience
The TearScience Experience
LipiView is an innovative device is used for observing the tear film. LipiView captures images of the tear film, processing 14 million pixels per second – more than a billion data points in total.
LipiView is an innovative device is used for observing the tear film. LipiView captures images of the tear film, processing 14 million pixels per second – more than a billion data points in total.
Meibomian Gland Evaluator is a hand-held tool used for evaluating meibomian gland secretions through gland expression, an important step in determining if glands are blocked.
Meibomian Gland Evaluator is a hand-held tool used for evaluating meibomian gland secretions through gland expression, an important step in determining if glands are blocked.
LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure.
LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure.
Specialty Eyecare Group Logo
Specialty Eyecare Group Logo
Dr. David Kading
Dr. David Kading
The TearScience Experience LipiView is an innovative device is used for observing the tear film. LipiView captures images of the tear film, processing 14 million pixels per second – more than a billion data points in total. Meibomian Gland Evaluator is a hand-held tool used for evaluating meibomian gland secretions through gland expression, an important step in determining if glands are blocked. LipiFlow Thermal Pulsation treats evaporative dry eye patients with a 12-minute, in-office procedure. Specialty Eyecare Group Logo Dr. David Kading

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.